Hepatocellular carcinoma: recent trends in the United States.

By H. B. EL‐SERAG. Gastroenterology, 2004

1,000 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Oncology

View Paper: https://www.semanticscholar.org/paper/8416cd4de07d4224aad1210c2197310a3368f343

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Llovet

In Hepatology

1. J. Llovet
2. J. Zucman‐Rossi
3. Jordi Bruix1 , 2
4. Riccardo Lencioni

In Oncology

1. J. Llovet

Citations in the corpus

• Alpha-fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound Alpha-fetoprotein in Early Hepatocellular Carcinoma (2009, background): “INTRODUCTION Hepatocellular carcinoma (HCC) is the fifth most common tumor and the third most common cause of cancer-related deaths worldwide (1,2).”
• MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations (2008, background): “Hepatocellular adenomas (HCA) and hepatocellular carcinomas (HCC) are liver tumors heterogeneous in nature with various risk factors, genetics alterations, and clinical features (1-3).”